

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 7.55849347 |
| 2 | coenzyme catabolic process (GO:0009109) | 6.19618290 |
| 3 | sulfur amino acid catabolic process (GO:0000098) | 5.75955644 |
| 4 | cellular modified amino acid catabolic process (GO:0042219) | 5.74751414 |
| 5 | somite rostral/caudal axis specification (GO:0032525) | 5.67725408 |
| 6 | maintenance of protein location in nucleus (GO:0051457) | 5.60846028 |
| 7 | NADH metabolic process (GO:0006734) | 5.57886398 |
| 8 | negative regulation of epidermis development (GO:0045683) | 5.56461440 |
| 9 | hormone catabolic process (GO:0042447) | 5.32183948 |
| 10 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.10547569 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 5.07441627 |
| 12 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.04494180 |
| 13 | response to dietary excess (GO:0002021) | 4.88819107 |
| 14 | phenol-containing compound catabolic process (GO:0019336) | 4.81127729 |
| 15 | epoxygenase P450 pathway (GO:0019373) | 4.81091340 |
| 16 | cellular glucuronidation (GO:0052695) | 4.81013683 |
| 17 | cytidine deamination (GO:0009972) | 4.80772198 |
| 18 | cytidine metabolic process (GO:0046087) | 4.80772198 |
| 19 | cytidine catabolic process (GO:0006216) | 4.80772198 |
| 20 | glucuronate metabolic process (GO:0019585) | 4.78169857 |
| 21 | uronic acid metabolic process (GO:0006063) | 4.78169857 |
| 22 | negative regulation of telomerase activity (GO:0051974) | 4.75492236 |
| 23 | rRNA transcription (GO:0009303) | 4.53282713 |
| 24 | muscle organ morphogenesis (GO:0048644) | 4.52658627 |
| 25 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.52574312 |
| 26 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.52522792 |
| 27 | urea metabolic process (GO:0019627) | 4.52505006 |
| 28 | angiotensin maturation (GO:0002003) | 4.48080242 |
| 29 | glycoside metabolic process (GO:0016137) | 4.47764777 |
| 30 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 4.46540531 |
| 31 | nitrogen cycle metabolic process (GO:0071941) | 4.40092797 |
| 32 | urea cycle (GO:0000050) | 4.38655609 |
| 33 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.36395441 |
| 34 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 4.31308875 |
| 35 | regulation of cilium movement (GO:0003352) | 4.28827348 |
| 36 | L-ascorbic acid metabolic process (GO:0019852) | 4.19087712 |
| 37 | primary alcohol catabolic process (GO:0034310) | 4.18217073 |
| 38 | histone H4-K5 acetylation (GO:0043981) | 4.15755340 |
| 39 | histone H4-K8 acetylation (GO:0043982) | 4.15755340 |
| 40 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.15400613 |
| 41 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.12104519 |
| 42 | nucleoside transmembrane transport (GO:1901642) | 4.07967257 |
| 43 | heme transport (GO:0015886) | 4.05520892 |
| 44 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.04752106 |
| 45 | biotin metabolic process (GO:0006768) | 4.04457944 |
| 46 | rRNA methylation (GO:0031167) | 4.03948807 |
| 47 | histone H4-K12 acetylation (GO:0043983) | 3.98060294 |
| 48 | * drug metabolic process (GO:0017144) | 3.97484503 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.96396418 |
| 50 | regulation of cholesterol esterification (GO:0010872) | 3.94264068 |
| 51 | notochord development (GO:0030903) | 3.91237039 |
| 52 | GDP-mannose metabolic process (GO:0019673) | 3.90983713 |
| 53 | cofactor catabolic process (GO:0051187) | 3.88219081 |
| 54 | primitive streak formation (GO:0090009) | 3.86691882 |
| 55 | transepithelial transport (GO:0070633) | 3.86435801 |
| 56 | phenylpropanoid metabolic process (GO:0009698) | 3.81763436 |
| 57 | vitamin A metabolic process (GO:0006776) | 3.77570751 |
| 58 | rRNA modification (GO:0000154) | 3.76376867 |
| 59 | flavonoid metabolic process (GO:0009812) | 3.75871363 |
| 60 | protein localization to kinetochore (GO:0034501) | 3.75564181 |
| 61 | cofactor transport (GO:0051181) | 3.73627419 |
| 62 | cullin deneddylation (GO:0010388) | 3.73217852 |
| 63 | bile acid metabolic process (GO:0008206) | 3.72267901 |
| 64 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.70917790 |
| 65 | fructose metabolic process (GO:0006000) | 3.69295290 |
| 66 | L-phenylalanine metabolic process (GO:0006558) | 3.65090797 |
| 67 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.65090797 |
| 68 | ethanol oxidation (GO:0006069) | 3.60584204 |
| 69 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.54993682 |
| 70 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.53100482 |
| 71 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.50153649 |
| 72 | omega-hydroxylase P450 pathway (GO:0097267) | 3.48810556 |
| 73 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.46291589 |
| 74 | drug catabolic process (GO:0042737) | 3.45839130 |
| 75 | bile acid and bile salt transport (GO:0015721) | 3.39266360 |
| 76 | proline metabolic process (GO:0006560) | 3.37512277 |
| 77 | negative regulation of telomere maintenance (GO:0032205) | 3.37275589 |
| 78 | protein deneddylation (GO:0000338) | 3.37210005 |
| 79 | exogenous drug catabolic process (GO:0042738) | 3.37177864 |
| 80 | regulation of translation in response to stress (GO:0043555) | 3.37053478 |
| 81 | glyoxylate metabolic process (GO:0046487) | 3.36882639 |
| 82 | cardiovascular system development (GO:0072358) | 3.34864791 |
| 83 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.32203258 |
| 84 | cysteine metabolic process (GO:0006534) | 3.31640443 |
| 85 | phospholipid efflux (GO:0033700) | 3.31175717 |
| 86 | intestinal absorption (GO:0050892) | 3.30965686 |
| 87 | xenobiotic catabolic process (GO:0042178) | 3.30105458 |
| 88 | mitochondrion distribution (GO:0048311) | 3.28896074 |
| 89 | L-phenylalanine catabolic process (GO:0006559) | 3.28537506 |
| 90 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.28537506 |
| 91 | proline biosynthetic process (GO:0006561) | 3.27349658 |
| 92 | modified amino acid transport (GO:0072337) | 3.25272839 |
| 93 | intestinal epithelial cell development (GO:0060576) | 3.25219191 |
| 94 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.24781237 |
| 95 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.24781237 |
| 96 | branched-chain amino acid catabolic process (GO:0009083) | 3.24312553 |
| 97 | ethanol metabolic process (GO:0006067) | 3.23587308 |
| 98 | * quinone metabolic process (GO:1901661) | 3.23204514 |
| 99 | maintenance of protein localization in organelle (GO:0072595) | 3.23111071 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.23024993 |
| 101 | COPI coating of Golgi vesicle (GO:0048205) | 3.22856055 |
| 102 | Golgi transport vesicle coating (GO:0048200) | 3.22856055 |
| 103 | protein retention in ER lumen (GO:0006621) | 3.21997865 |
| 104 | protein maturation by protein folding (GO:0022417) | 3.20145760 |
| 105 | oxaloacetate metabolic process (GO:0006107) | 3.20012953 |
| 106 | interferon-gamma production (GO:0032609) | 3.19299300 |
| 107 | proline transport (GO:0015824) | 3.18970135 |
| 108 | aromatic amino acid family catabolic process (GO:0009074) | 3.17057754 |
| 109 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.15937179 |
| 110 | cellular aldehyde metabolic process (GO:0006081) | 3.15164362 |
| 111 | thyroid hormone generation (GO:0006590) | 3.14476421 |
| 112 | valine metabolic process (GO:0006573) | 3.11585111 |
| 113 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.11210768 |
| 114 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.08338741 |
| 115 | mitotic sister chromatid segregation (GO:0000070) | 3.08131506 |
| 116 | kynurenine metabolic process (GO:0070189) | 3.06807162 |
| 117 | bile acid biosynthetic process (GO:0006699) | 3.06301073 |
| 118 | icosanoid secretion (GO:0032309) | 3.05372355 |
| 119 | arachidonic acid secretion (GO:0050482) | 3.05372355 |
| 120 | transcription from mitochondrial promoter (GO:0006390) | 3.03982342 |
| 121 | indole-containing compound catabolic process (GO:0042436) | 3.02557628 |
| 122 | indolalkylamine catabolic process (GO:0046218) | 3.02557628 |
| 123 | tryptophan catabolic process (GO:0006569) | 3.02557628 |
| 124 | regulation of triglyceride catabolic process (GO:0010896) | 3.01860268 |
| 125 | serine family amino acid catabolic process (GO:0009071) | 3.01594934 |
| 126 | DNA damage response, detection of DNA damage (GO:0042769) | 3.00802197 |
| 127 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.99989151 |
| 128 | cellular response to cadmium ion (GO:0071276) | 2.99684971 |
| 129 | nucleoside transport (GO:0015858) | 2.99224793 |
| 130 | retinoic acid receptor signaling pathway (GO:0048384) | 2.97534516 |
| 131 | regulation of bile acid biosynthetic process (GO:0070857) | 2.96839447 |
| 132 | cellular amino acid catabolic process (GO:0009063) | 2.95209000 |
| 133 | organic cation transport (GO:0015695) | 2.94219963 |
| 134 | regulation of telomerase activity (GO:0051972) | 2.94035818 |
| 135 | tricarboxylic acid cycle (GO:0006099) | 2.93802376 |
| 136 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.92842476 |
| 137 | lipoprotein transport (GO:0042953) | 2.91531284 |
| 138 | regulation of guanylate cyclase activity (GO:0031282) | 2.91117988 |
| 139 | progesterone metabolic process (GO:0042448) | 2.90075179 |
| 140 | maternal placenta development (GO:0001893) | 2.90009375 |
| 141 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 2.88361522 |
| 142 | * cyclooxygenase pathway (GO:0019371) | 2.87712666 |
| 143 | glycolipid catabolic process (GO:0019377) | 2.87060962 |
| 144 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.86974829 |
| 145 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.86932927 |
| 146 | receptor recycling (GO:0001881) | 2.86753660 |
| 147 | heterochromatin organization (GO:0070828) | 2.86443164 |
| 148 | glutathione derivative biosynthetic process (GO:1901687) | 2.84108529 |
| 149 | glutathione derivative metabolic process (GO:1901685) | 2.84108529 |
| 150 | vitamin biosynthetic process (GO:0009110) | 2.82231511 |
| 151 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.81455112 |
| 152 | very long-chain fatty acid metabolic process (GO:0000038) | 2.79165492 |
| 153 | fibrinolysis (GO:0042730) | 2.78501500 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.77958408 |
| 155 | regulation of cholesterol metabolic process (GO:0090181) | 2.77387413 |
| 156 | virion attachment to host cell (GO:0019062) | 2.76869797 |
| 157 | adhesion of symbiont to host cell (GO:0044650) | 2.76869797 |
| 158 | primary alcohol metabolic process (GO:0034308) | 2.75590600 |
| 159 | cellular copper ion homeostasis (GO:0006878) | 2.71243739 |
| 160 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70082410 |
| 161 | aldehyde catabolic process (GO:0046185) | 2.69657714 |
| 162 | glutathione metabolic process (GO:0006749) | 2.65935553 |
| 163 | plasma lipoprotein particle assembly (GO:0034377) | 2.63991145 |
| 164 | protein-lipid complex assembly (GO:0065005) | 2.63290598 |
| 165 | retinal metabolic process (GO:0042574) | 2.60357252 |
| 166 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.59790744 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.58211358 |
| 168 | proteasome assembly (GO:0043248) | 2.57746696 |
| 169 | cellular response to zinc ion (GO:0071294) | 2.57101633 |
| 170 | adhesion of symbiont to host (GO:0044406) | 2.56000913 |
| 171 | renal system process involved in regulation of blood volume (GO:0001977) | 2.55107636 |
| 172 | regulation of protein activation cascade (GO:2000257) | 2.54304874 |
| 173 | monosaccharide biosynthetic process (GO:0046364) | 2.53595673 |
| 174 | arginine metabolic process (GO:0006525) | 2.53397010 |
| 175 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.51919949 |
| 176 | glutathione biosynthetic process (GO:0006750) | 2.51884597 |
| 177 | daunorubicin metabolic process (GO:0044597) | 10.5718105 |
| 178 | polyketide metabolic process (GO:0030638) | 10.5718105 |
| 179 | doxorubicin metabolic process (GO:0044598) | 10.5718105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 6.44648138 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 6.44648138 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 6.44648138 |
| 4 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.00209432 |
| 5 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 3.45277207 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.27332357 |
| 7 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 3.14027796 |
| 8 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.05108735 |
| 9 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 3.03923578 |
| 10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.87710263 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.74216831 |
| 12 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.71568766 |
| 13 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.65858720 |
| 14 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.61237356 |
| 15 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.59626381 |
| 16 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.59319013 |
| 17 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 2.54490505 |
| 18 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.50850647 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.48129037 |
| 20 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42647067 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.31403012 |
| 22 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.29490827 |
| 23 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 2.27695760 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.26741748 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.25678014 |
| 26 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.22486187 |
| 27 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.21907049 |
| 28 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13412997 |
| 29 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03483710 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 2.02477144 |
| 31 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99524820 |
| 32 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.96950485 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95457481 |
| 34 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.92577012 |
| 35 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.90255230 |
| 36 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.86022372 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.80920255 |
| 38 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.80633835 |
| 39 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76190987 |
| 40 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73804241 |
| 41 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.73680190 |
| 42 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.71809986 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71429838 |
| 44 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.68456838 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.68249433 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.65005886 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.62643028 |
| 48 | * OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.62406843 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59244284 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.58390437 |
| 51 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.54520721 |
| 52 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.53952579 |
| 53 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.50878746 |
| 54 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.49287036 |
| 55 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.48405397 |
| 56 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.48404941 |
| 57 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48087290 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.42498200 |
| 59 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.42024910 |
| 60 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.40253251 |
| 61 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38108586 |
| 62 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.37542811 |
| 63 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35242243 |
| 64 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.35211995 |
| 65 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.33733663 |
| 66 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.31321285 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.30211194 |
| 68 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.29544312 |
| 69 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.28157115 |
| 70 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.27195051 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25660432 |
| 72 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25011949 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24567528 |
| 74 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.23542391 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22849241 |
| 76 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.21277364 |
| 77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.21219570 |
| 78 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20956687 |
| 79 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.19467705 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19466222 |
| 81 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.19067599 |
| 82 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18369025 |
| 83 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17510841 |
| 84 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16077764 |
| 85 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.15486545 |
| 86 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15363431 |
| 87 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.15120035 |
| 88 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15078714 |
| 89 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14724349 |
| 90 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14307360 |
| 91 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13813325 |
| 92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.13719492 |
| 93 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.13156368 |
| 94 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.12575674 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.11930314 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 1.11058241 |
| 97 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.10778252 |
| 98 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10646289 |
| 99 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.09035593 |
| 100 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08556143 |
| 101 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07971279 |
| 102 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07408277 |
| 103 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.07292298 |
| 104 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.05958178 |
| 105 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.04531663 |
| 106 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.04491970 |
| 107 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03967058 |
| 108 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03732239 |
| 109 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03601058 |
| 110 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03421904 |
| 111 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02927613 |
| 112 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02330706 |
| 113 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01786456 |
| 114 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.01415383 |
| 115 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00197812 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99311330 |
| 117 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99245739 |
| 118 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.97837881 |
| 119 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.97761682 |
| 120 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.97277738 |
| 121 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.97266995 |
| 122 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96574952 |
| 123 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.96045064 |
| 124 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95655076 |
| 125 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.95485398 |
| 126 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.94797555 |
| 127 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.94254793 |
| 128 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91393726 |
| 129 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.89760831 |
| 130 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.89540736 |
| 131 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.89163470 |
| 132 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88671525 |
| 133 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.88280589 |
| 134 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.87957637 |
| 135 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87605057 |
| 136 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87468171 |
| 137 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.83932465 |
| 138 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.83663834 |
| 139 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.83336102 |
| 140 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.83092441 |
| 141 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.82703713 |
| 142 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.81444946 |
| 143 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.81424713 |
| 144 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.81033020 |
| 145 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.80767545 |
| 146 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.79248904 |
| 147 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.77962323 |
| 148 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.77693175 |
| 149 | SETDB1_19884257_ChIP-Seq_MESCs_Mouse | 0.77572406 |
| 150 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.76798746 |
| 151 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.76464142 |
| 152 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.76266061 |
| 153 | P68_20966046_ChIP-Seq_HELA_Human | 0.76121347 |
| 154 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.76115202 |
| 155 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.76005521 |
| 156 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.75673887 |
| 157 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.75437808 |
| 158 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72694507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.07847197 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.37326078 |
| 3 | MP0002254_reproductive_system_inflammat | 4.26337495 |
| 4 | MP0005360_urolithiasis | 4.02389468 |
| 5 | MP0006292_abnormal_olfactory_placode | 3.80189727 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 3.60013787 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.40381221 |
| 8 | MP0005394_taste/olfaction_phenotype | 3.25100768 |
| 9 | MP0005499_abnormal_olfactory_system | 3.25100768 |
| 10 | MP0004858_abnormal_nervous_system | 3.11209481 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.83476553 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.82282254 |
| 13 | MP0003122_maternal_imprinting | 2.77092217 |
| 14 | MP0005365_abnormal_bile_salt | 2.77071087 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.73923522 |
| 16 | MP0002332_abnormal_exercise_endurance | 2.57107297 |
| 17 | MP0004043_abnormal_pH_regulation | 2.57011762 |
| 18 | MP0005075_abnormal_melanosome_morpholog | 2.54031009 |
| 19 | MP0009379_abnormal_foot_pigmentation | 2.43421035 |
| 20 | MP0005058_abnormal_lysosome_morphology | 2.29642815 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.24005980 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.18936062 |
| 23 | MP0000678_abnormal_parathyroid_gland | 2.07770200 |
| 24 | MP0002653_abnormal_ependyma_morphology | 2.06125171 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.80343169 |
| 26 | MP0009697_abnormal_copulation | 1.77574105 |
| 27 | MP0008961_abnormal_basal_metabolism | 1.76369255 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.75730026 |
| 29 | MP0003705_abnormal_hypodermis_morpholog | 1.73836395 |
| 30 | MP0005332_abnormal_amino_acid | 1.72412587 |
| 31 | MP0008260_abnormal_autophagy | 1.71087472 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.68382230 |
| 33 | MP0004957_abnormal_blastocyst_morpholog | 1.65422093 |
| 34 | MP0001764_abnormal_homeostasis | 1.64783431 |
| 35 | MP0003938_abnormal_ear_development | 1.64462853 |
| 36 | MP0005266_abnormal_metabolism | 1.63618936 |
| 37 | MP0003941_abnormal_skin_development | 1.54817754 |
| 38 | MP0008789_abnormal_olfactory_epithelium | 1.53431142 |
| 39 | MP0010030_abnormal_orbit_morphology | 1.48176871 |
| 40 | MP0003121_genomic_imprinting | 1.47994097 |
| 41 | MP0010329_abnormal_lipoprotein_level | 1.47290674 |
| 42 | MP0005319_abnormal_enzyme/_coenzyme | 1.43555196 |
| 43 | MP0003252_abnormal_bile_duct | 1.40302036 |
| 44 | MP0005451_abnormal_body_composition | 1.40079422 |
| 45 | MP0004147_increased_porphyrin_level | 1.39780163 |
| 46 | MP0005166_decreased_susceptibility_to | 1.38570339 |
| 47 | MP0005408_hypopigmentation | 1.37851666 |
| 48 | MP0002277_abnormal_respiratory_mucosa | 1.36979811 |
| 49 | MP0005501_abnormal_skin_physiology | 1.36296671 |
| 50 | MP0002127_abnormal_cardiovascular_syste | 1.34155831 |
| 51 | MP0005670_abnormal_white_adipose | 1.31484613 |
| 52 | MP0003329_amyloid_beta_deposits | 1.31410049 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.31021386 |
| 54 | MP0005165_increased_susceptibility_to | 1.30807754 |
| 55 | MP0001666_abnormal_nutrient_absorption | 1.30362310 |
| 56 | MP0002132_abnormal_respiratory_system | 1.27701042 |
| 57 | MP0003186_abnormal_redox_activity | 1.27072553 |
| 58 | MP0003075_altered_response_to | 1.26141119 |
| 59 | MP0002877_abnormal_melanocyte_morpholog | 1.25233851 |
| 60 | MP0000920_abnormal_myelination | 1.24275485 |
| 61 | MP0000762_abnormal_tongue_morphology | 1.20271336 |
| 62 | MP0003718_maternal_effect | 1.19496426 |
| 63 | MP0008438_abnormal_cutaneous_collagen | 1.19122099 |
| 64 | MP0000604_amyloidosis | 1.18540710 |
| 65 | MP0000049_abnormal_middle_ear | 1.18283547 |
| 66 | MP0003283_abnormal_digestive_organ | 1.18215399 |
| 67 | MP0002932_abnormal_joint_morphology | 1.17197637 |
| 68 | MP0005023_abnormal_wound_healing | 1.16519052 |
| 69 | MP0008872_abnormal_physiological_respon | 1.15518528 |
| 70 | MP0003315_abnormal_perineum_morphology | 1.14210892 |
| 71 | MP0004272_abnormal_basement_membrane | 1.12814513 |
| 72 | MP0001849_ear_inflammation | 1.10417656 |
| 73 | MP0002876_abnormal_thyroid_physiology | 1.09683450 |
| 74 | MP0000609_abnormal_liver_physiology | 1.09604622 |
| 75 | MP0001672_abnormal_embryogenesis/_devel | 1.08485294 |
| 76 | MP0005380_embryogenesis_phenotype | 1.08485294 |
| 77 | MP0009840_abnormal_foam_cell | 1.04733108 |
| 78 | MP0006082_CNS_inflammation | 1.03739702 |
| 79 | MP0008057_abnormal_DNA_replication | 1.03339171 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 1.01584599 |
| 81 | MP0003123_paternal_imprinting | 1.01301459 |
| 82 | MP0002970_abnormal_white_adipose | 1.00207491 |
| 83 | MP0010352_gastrointestinal_tract_polyps | 0.98600038 |
| 84 | MP0001293_anophthalmia | 0.98181945 |
| 85 | MP0003984_embryonic_growth_retardation | 0.98127091 |
| 86 | MP0002233_abnormal_nose_morphology | 0.97796656 |
| 87 | MP0002092_abnormal_eye_morphology | 0.97082055 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.95947578 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.94078840 |
| 90 | MP0010155_abnormal_intestine_physiology | 0.94029290 |
| 91 | MP0005376_homeostasis/metabolism_phenot | 0.93770330 |
| 92 | MP0009643_abnormal_urine_homeostasis | 0.93730253 |
| 93 | MP0003119_abnormal_digestive_system | 0.93302394 |
| 94 | MP0003879_abnormal_hair_cell | 0.90723308 |
| 95 | MP0000537_abnormal_urethra_morphology | 0.90277027 |
| 96 | MP0005083_abnormal_biliary_tract | 0.88954323 |
| 97 | MP0000579_abnormal_nail_morphology | 0.88563061 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.87610608 |
| 99 | MP0000467_abnormal_esophagus_morphology | 0.87333258 |
| 100 | MP0001664_abnormal_digestion | 0.86262660 |
| 101 | MP0000462_abnormal_digestive_system | 0.84572233 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.84308326 |
| 103 | MP0004133_heterotaxia | 0.83702424 |
| 104 | MP0000538_abnormal_urinary_bladder | 0.82946342 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.82031320 |
| 106 | MP0005623_abnormal_meninges_morphology | 0.81677133 |
| 107 | MP0003950_abnormal_plasma_membrane | 0.79969734 |
| 108 | MP0000858_altered_metastatic_potential | 0.79524701 |
| 109 | MP0009780_abnormal_chondrocyte_physiolo | 0.78454235 |
| 110 | MP0001216_abnormal_epidermal_layer | 0.76235641 |
| 111 | MP0002909_abnormal_adrenal_gland | 0.75763415 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 0.75705636 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74219393 |
| 114 | MP0001188_hyperpigmentation | 0.74084661 |
| 115 | MP0002060_abnormal_skin_morphology | 0.73951202 |
| 116 | MP0002136_abnormal_kidney_physiology | 0.73269007 |
| 117 | MP0005636_abnormal_mineral_homeostasis | 0.73071833 |
| 118 | MP0002249_abnormal_larynx_morphology | 0.72894475 |
| 119 | MP0009333_abnormal_splenocyte_physiolog | 0.72144073 |
| 120 | MP0000343_altered_response_to | 0.71378620 |
| 121 | MP0002114_abnormal_axial_skeleton | 0.71204475 |
| 122 | MP0003638_abnormal_response/metabolism_ | 0.71051594 |
| 123 | MP0005395_other_phenotype | 0.70498257 |
| 124 | MP0000477_abnormal_intestine_morphology | 0.69430420 |
| 125 | MP0000681_abnormal_thyroid_gland | 0.69225064 |
| 126 | MP0001243_abnormal_dermal_layer | 0.69207756 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.69158406 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.67979978 |
| 129 | MP0001881_abnormal_mammary_gland | 0.67040499 |
| 130 | MP0004142_abnormal_muscle_tone | 0.65717443 |
| 131 | MP0008469_abnormal_protein_level | 0.65111405 |
| 132 | MP0001756_abnormal_urination | 0.64684856 |
| 133 | MP0003195_calcinosis | 0.63690069 |
| 134 | MP0000358_abnormal_cell_content/ | 0.62805683 |
| 135 | MP0003866_abnormal_defecation | 0.62463374 |
| 136 | MP0002086_abnormal_extraembryonic_tissu | 0.61861613 |
| 137 | MP0004883_abnormal_blood_vessel | 0.61840601 |
| 138 | MP0010771_integument_phenotype | 0.61386026 |
| 139 | MP0010386_abnormal_urinary_bladder | 0.60966744 |
| 140 | MP0004270_analgesia | 0.59996961 |
| 141 | MP0009763_increased_sensitivity_to | 0.59430646 |
| 142 | MP0002085_abnormal_embryonic_tissue | 0.58816708 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.58735695 |
| 144 | MP0000598_abnormal_liver_morphology | 0.58020341 |
| 145 | MP0008770_decreased_survivor_rate | 0.55337907 |
| 146 | MP0005330_cardiomyopathy | 0.55006465 |
| 147 | MP0002796_impaired_skin_barrier | 0.54957771 |
| 148 | MP0005391_vision/eye_phenotype | 0.54310070 |
| 149 | MP0003693_abnormal_embryo_hatching | 0.54101618 |
| 150 | MP0003690_abnormal_glial_cell | 0.53884517 |
| 151 | MP0009642_abnormal_blood_homeostasis | 0.53817614 |
| 152 | MP0003755_abnormal_palate_morphology | 0.53462330 |
| 153 | MP0001348_abnormal_lacrimal_gland | 0.53062007 |
| 154 | MP0000350_abnormal_cell_proliferation | 0.52914832 |
| 155 | MP0004782_abnormal_surfactant_physiolog | 0.51968327 |
| 156 | MP0009115_abnormal_fat_cell | 0.51627823 |
| 157 | MP0002269_muscular_atrophy | 0.50823312 |
| 158 | MP0002822_catalepsy | 0.48032759 |
| 159 | MP0001270_distended_abdomen | 0.47915797 |
| 160 | MP0003868_abnormal_feces_composition | 0.47730057 |
| 161 | MP0000490_abnormal_crypts_of | 0.47188790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.84814061 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 6.36865167 |
| 3 | Multiple enchondromatosis (HP:0005701) | 5.58555993 |
| 4 | Hepatoblastoma (HP:0002884) | 5.56081144 |
| 5 | Abnormality of the lower motor neuron (HP:0002366) | 4.73398140 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.61048188 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.54620752 |
| 8 | Hydroxyprolinuria (HP:0003080) | 4.17470249 |
| 9 | Abnormality of proline metabolism (HP:0010907) | 4.17470249 |
| 10 | Hyperglycinuria (HP:0003108) | 3.94503394 |
| 11 | Rib fusion (HP:0000902) | 3.82384307 |
| 12 | Abnormal cartilage morphology (HP:0002763) | 3.82375650 |
| 13 | Ragged-red muscle fibers (HP:0003200) | 3.81048238 |
| 14 | Gout (HP:0001997) | 3.69264811 |
| 15 | Fat malabsorption (HP:0002630) | 3.67070904 |
| 16 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.59692807 |
| 17 | Hyperventilation (HP:0002883) | 3.56778192 |
| 18 | Malnutrition (HP:0004395) | 3.52058655 |
| 19 | Testicular atrophy (HP:0000029) | 3.29211144 |
| 20 | Neoplasm of striated muscle (HP:0009728) | 3.28536376 |
| 21 | Ependymoma (HP:0002888) | 3.22562605 |
| 22 | Reduced antithrombin III activity (HP:0001976) | 3.22055238 |
| 23 | Rhabdomyosarcoma (HP:0002859) | 3.21856562 |
| 24 | Steatorrhea (HP:0002570) | 3.16005434 |
| 25 | Complement deficiency (HP:0004431) | 3.10802103 |
| 26 | Abnormality of complement system (HP:0005339) | 3.07116651 |
| 27 | Hypoplasia of the fovea (HP:0007750) | 3.05171856 |
| 28 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.05171856 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.03593908 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.03593908 |
| 31 | Partial duplication of thumb phalanx (HP:0009944) | 3.03450060 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.01600306 |
| 33 | Vaginal fistula (HP:0004320) | 3.01555490 |
| 34 | Abnormality of glycolysis (HP:0004366) | 3.00573079 |
| 35 | Increased serum pyruvate (HP:0003542) | 3.00573079 |
| 36 | Anomalous pulmonary venous return (HP:0010772) | 2.94886000 |
| 37 | Vertebral compression fractures (HP:0002953) | 2.91803738 |
| 38 | Hypolipoproteinemia (HP:0010981) | 2.89726738 |
| 39 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.87571125 |
| 40 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.87571125 |
| 41 | Rectal fistula (HP:0100590) | 2.86801487 |
| 42 | Rectovaginal fistula (HP:0000143) | 2.86801487 |
| 43 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.84793913 |
| 44 | Deep venous thrombosis (HP:0002625) | 2.81697357 |
| 45 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.80123221 |
| 46 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.75799542 |
| 47 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74661167 |
| 48 | Amyotrophic lateral sclerosis (HP:0007354) | 2.70884634 |
| 49 | Prolonged partial thromboplastin time (HP:0003645) | 2.70494579 |
| 50 | Embryonal renal neoplasm (HP:0011794) | 2.69075253 |
| 51 | Bifid tongue (HP:0010297) | 2.64721611 |
| 52 | Partial duplication of the phalanx of hand (HP:0009999) | 2.63423280 |
| 53 | Nausea (HP:0002018) | 2.62408443 |
| 54 | Tetraplegia (HP:0002445) | 2.60576759 |
| 55 | Abnormality of the pulmonary veins (HP:0011718) | 2.51092803 |
| 56 | Fused cervical vertebrae (HP:0002949) | 2.50837079 |
| 57 | Axonal loss (HP:0003447) | 2.49928785 |
| 58 | Glomerulonephritis (HP:0000099) | 2.49412424 |
| 59 | Generalized hypotonia (HP:0001290) | 2.48530121 |
| 60 | Cholecystitis (HP:0001082) | 2.48331672 |
| 61 | Abnormal gallbladder physiology (HP:0012438) | 2.48331672 |
| 62 | Progressive muscle weakness (HP:0003323) | 2.48097945 |
| 63 | Abnormality of vitamin metabolism (HP:0100508) | 2.47795539 |
| 64 | Skin nodule (HP:0200036) | 2.47767337 |
| 65 | Hypochromic anemia (HP:0001931) | 2.47708103 |
| 66 | Trismus (HP:0000211) | 2.47694905 |
| 67 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.46128569 |
| 68 | Horizontal nystagmus (HP:0000666) | 2.44777718 |
| 69 | Abnormality of the salivary glands (HP:0010286) | 2.43586687 |
| 70 | Confusion (HP:0001289) | 2.43137649 |
| 71 | Cerebral edema (HP:0002181) | 2.40907997 |
| 72 | Hyperammonemia (HP:0001987) | 2.39268062 |
| 73 | Conjugated hyperbilirubinemia (HP:0002908) | 2.38857843 |
| 74 | Ileus (HP:0002595) | 2.37784658 |
| 75 | Intestinal fistula (HP:0100819) | 2.37692037 |
| 76 | Abnormality of the fovea (HP:0000493) | 2.36834290 |
| 77 | Vascular calcification (HP:0004934) | 2.36137775 |
| 78 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.33930110 |
| 79 | Abnormality of urine glucose concentration (HP:0011016) | 2.33671620 |
| 80 | Glycosuria (HP:0003076) | 2.33671620 |
| 81 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33022650 |
| 82 | Shawl scrotum (HP:0000049) | 2.32006585 |
| 83 | Stridor (HP:0010307) | 2.31840774 |
| 84 | Acute encephalopathy (HP:0006846) | 2.27878680 |
| 85 | Ketoacidosis (HP:0001993) | 2.27362116 |
| 86 | Nasolacrimal duct obstruction (HP:0000579) | 2.27296826 |
| 87 | Abnormality of nucleobase metabolism (HP:0010932) | 2.26619272 |
| 88 | Sensory axonal neuropathy (HP:0003390) | 2.26539260 |
| 89 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.26300873 |
| 90 | Generalized aminoaciduria (HP:0002909) | 2.26193339 |
| 91 | Short humerus (HP:0005792) | 2.26047298 |
| 92 | Progressive external ophthalmoplegia (HP:0000590) | 2.25777590 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.24117151 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 2.22670213 |
| 95 | Hyperglycinemia (HP:0002154) | 2.22524097 |
| 96 | Posterior subcapsular cataract (HP:0007787) | 2.19719390 |
| 97 | Paraparesis (HP:0002385) | 2.19309958 |
| 98 | Megaloblastic anemia (HP:0001889) | 2.18776172 |
| 99 | Microvesicular hepatic steatosis (HP:0001414) | 2.18565893 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.17771769 |
| 101 | Abnormality of purine metabolism (HP:0004352) | 2.17677511 |
| 102 | Intrahepatic cholestasis (HP:0001406) | 2.17461506 |
| 103 | Patchy hypopigmentation of hair (HP:0011365) | 2.17391113 |
| 104 | Preauricular pit (HP:0004467) | 2.17308237 |
| 105 | Periauricular skin pits (HP:0100277) | 2.17308237 |
| 106 | Abnormal lung lobation (HP:0002101) | 2.16122934 |
| 107 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14803804 |
| 108 | Hyperparathyroidism (HP:0000843) | 2.13687295 |
| 109 | Microretrognathia (HP:0000308) | 2.13112306 |
| 110 | Hyperactive renin-angiotensin system (HP:0000841) | 2.12707822 |
| 111 | Hyperuricemia (HP:0002149) | 2.12221549 |
| 112 | Increased purine levels (HP:0004368) | 2.12221549 |
| 113 | Abnormality of serum amino acid levels (HP:0003112) | 2.12150859 |
| 114 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.10929182 |
| 115 | Xanthomatosis (HP:0000991) | 2.10537478 |
| 116 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.09407612 |
| 117 | Villous atrophy (HP:0011473) | 2.09407612 |
| 118 | Ketosis (HP:0001946) | 2.07101723 |
| 119 | Impulsivity (HP:0100710) | 2.06031327 |
| 120 | Upper motor neuron abnormality (HP:0002127) | 2.03820936 |
| 121 | Osteolytic defects of the hand bones (HP:0009699) | 2.03728138 |
| 122 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.03728138 |
| 123 | Abnormality of the Achilles tendon (HP:0005109) | 2.03179927 |
| 124 | Dicarboxylic aciduria (HP:0003215) | 2.02825842 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02825842 |
| 126 | Large earlobe (HP:0009748) | 2.02441423 |
| 127 | Vacuolated lymphocytes (HP:0001922) | 2.02070341 |
| 128 | Abnormality of the astrocytes (HP:0100707) | 2.01807967 |
| 129 | Astrocytoma (HP:0009592) | 2.01807967 |
| 130 | Hyperphosphaturia (HP:0003109) | 2.01683301 |
| 131 | Metabolic acidosis (HP:0001942) | 2.01503136 |
| 132 | Pseudobulbar signs (HP:0002200) | 2.00916646 |
| 133 | Tongue fasciculations (HP:0001308) | 2.00384420 |
| 134 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.99641572 |
| 135 | Preauricular skin tag (HP:0000384) | 1.98235849 |
| 136 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98134202 |
| 137 | Amyloidosis (HP:0011034) | 1.97889260 |
| 138 | Status epilepticus (HP:0002133) | 1.97250177 |
| 139 | Nephrolithiasis (HP:0000787) | 1.97211745 |
| 140 | Proximal tubulopathy (HP:0000114) | 1.96054240 |
| 141 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.95233154 |
| 142 | Abnormality of methionine metabolism (HP:0010901) | 1.95210933 |
| 143 | Increased intramyocellular lipid droplets (HP:0012240) | 1.94891126 |
| 144 | Cheilitis (HP:0100825) | 1.94722165 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94571213 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94571213 |
| 147 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94571213 |
| 148 | Acute necrotizing encephalopathy (HP:0006965) | 1.93917388 |
| 149 | Increased muscle lipid content (HP:0009058) | 1.92779946 |
| 150 | Abnormal hair laboratory examination (HP:0003328) | 1.92376087 |
| 151 | Amblyopia (HP:0000646) | 1.92221163 |
| 152 | Vomiting (HP:0002013) | 1.91842672 |
| 153 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.91682320 |
| 154 | Alkalosis (HP:0001948) | 1.91346028 |
| 155 | Hepatic necrosis (HP:0002605) | 1.90667059 |
| 156 | Sparse eyelashes (HP:0000653) | 1.89981488 |
| 157 | Irritability (HP:0000737) | 1.89513759 |
| 158 | Abnormality of vitamin B metabolism (HP:0004340) | 1.89009792 |
| 159 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.88411335 |
| 160 | Type I transferrin isoform profile (HP:0003642) | 1.88034025 |
| 161 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.87893612 |
| 162 | Multiple lipomas (HP:0001012) | 1.87367604 |
| 163 | Lethargy (HP:0001254) | 1.86438261 |
| 164 | Hypokinesia (HP:0002375) | 1.86389664 |
| 165 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.85739493 |
| 166 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.83756094 |
| 167 | White forelock (HP:0002211) | 1.83053096 |
| 168 | Achilles tendon contracture (HP:0001771) | 1.82722998 |
| 169 | Abnormal biliary tract physiology (HP:0012439) | 1.82325696 |
| 170 | Bile duct proliferation (HP:0001408) | 1.82325696 |
| 171 | Neoplasm of the heart (HP:0100544) | 1.81709393 |
| 172 | Spastic tetraparesis (HP:0001285) | 1.81628607 |
| 173 | Rough bone trabeculation (HP:0100670) | 1.81173905 |
| 174 | Spastic paraparesis (HP:0002313) | 1.80040630 |
| 175 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.78878272 |
| 176 | Nephritis (HP:0000123) | 1.78521829 |
| 177 | Premature rupture of membranes (HP:0001788) | 1.77962075 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.95629498 |
| 2 | GRK5 | 5.86569976 |
| 3 | ERN1 | 5.16985706 |
| 4 | GRK6 | 4.88320974 |
| 5 | NME2 | 3.63286327 |
| 6 | TESK1 | 3.60002994 |
| 7 | PBK | 3.47438102 |
| 8 | ADRBK2 | 3.42807565 |
| 9 | GRK1 | 3.32945488 |
| 10 | ARAF | 3.17104873 |
| 11 | MAP3K12 | 2.76819007 |
| 12 | TGFBR2 | 2.70577225 |
| 13 | GRK7 | 2.63052055 |
| 14 | CSF1R | 2.60230745 |
| 15 | LIMK1 | 2.55494929 |
| 16 | TYRO3 | 2.47812898 |
| 17 | MATK | 2.38570688 |
| 18 | MAPK7 | 2.38161139 |
| 19 | PIM2 | 2.27350920 |
| 20 | TTK | 2.15890453 |
| 21 | IRAK3 | 2.12436349 |
| 22 | RIPK1 | 2.04722942 |
| 23 | MYLK | 2.01159315 |
| 24 | MOS | 1.98064077 |
| 25 | WNK1 | 1.86705947 |
| 26 | VRK2 | 1.85111630 |
| 27 | PRKG2 | 1.80467263 |
| 28 | MET | 1.79542920 |
| 29 | MAP2K4 | 1.78754081 |
| 30 | BCKDK | 1.72650160 |
| 31 | EIF2AK1 | 1.71293802 |
| 32 | NTRK1 | 1.69737420 |
| 33 | MAP3K3 | 1.65705804 |
| 34 | STK10 | 1.65417256 |
| 35 | CAMK4 | 1.60024831 |
| 36 | DAPK1 | 1.52588426 |
| 37 | AKT3 | 1.48828393 |
| 38 | ACVR1B | 1.38644957 |
| 39 | ADRBK1 | 1.36941979 |
| 40 | EPHA2 | 1.30305574 |
| 41 | ILK | 1.29754474 |
| 42 | CAMK2G | 1.28189548 |
| 43 | SMG1 | 1.27876477 |
| 44 | MARK2 | 1.22621162 |
| 45 | WNK3 | 1.21934350 |
| 46 | CDK7 | 1.20016236 |
| 47 | PAK4 | 1.18563580 |
| 48 | MAP2K6 | 1.16758746 |
| 49 | STK16 | 1.16398173 |
| 50 | DAPK3 | 1.13584552 |
| 51 | SCYL2 | 1.11114291 |
| 52 | MAPKAPK5 | 1.05523091 |
| 53 | MAP3K11 | 1.03580900 |
| 54 | BRAF | 1.01904673 |
| 55 | BRSK1 | 0.96413014 |
| 56 | MAP3K7 | 0.93521192 |
| 57 | HIPK2 | 0.92157800 |
| 58 | MAP3K2 | 0.91935066 |
| 59 | PAK6 | 0.80408341 |
| 60 | CAMK2B | 0.79867305 |
| 61 | CHEK2 | 0.78390029 |
| 62 | TBK1 | 0.76877999 |
| 63 | MAPK12 | 0.76692505 |
| 64 | CAMK2D | 0.74260002 |
| 65 | LATS2 | 0.73443845 |
| 66 | AKT2 | 0.72331699 |
| 67 | PRKCI | 0.71310721 |
| 68 | PLK1 | 0.70787504 |
| 69 | FGFR3 | 0.69951591 |
| 70 | MAP3K9 | 0.68645191 |
| 71 | DDR2 | 0.68525111 |
| 72 | KDR | 0.68067618 |
| 73 | MAP3K1 | 0.65541586 |
| 74 | LRRK2 | 0.64376992 |
| 75 | PDPK1 | 0.63440707 |
| 76 | MAP3K8 | 0.59882669 |
| 77 | OXSR1 | 0.57513793 |
| 78 | NME1 | 0.56957038 |
| 79 | DYRK2 | 0.55688937 |
| 80 | CSK | 0.55444857 |
| 81 | MAP3K10 | 0.53337746 |
| 82 | PRPF4B | 0.52818362 |
| 83 | MST4 | 0.52789845 |
| 84 | CSNK1G3 | 0.52607546 |
| 85 | ERBB2 | 0.50903010 |
| 86 | PDGFRA | 0.49780827 |
| 87 | PTK2 | 0.48712810 |
| 88 | FGFR4 | 0.48435176 |
| 89 | ROCK2 | 0.46246696 |
| 90 | AURKB | 0.43352290 |
| 91 | TRIB3 | 0.43297326 |
| 92 | AURKA | 0.42296007 |
| 93 | PRKCG | 0.41067504 |
| 94 | FER | 0.40690411 |
| 95 | MAPK4 | 0.40301889 |
| 96 | IGF1R | 0.39992501 |
| 97 | SIK1 | 0.38950020 |
| 98 | EPHB1 | 0.37597855 |
| 99 | MST1R | 0.37567441 |
| 100 | PRKCD | 0.37513671 |
| 101 | MAPK11 | 0.37201716 |
| 102 | NEK1 | 0.36073072 |
| 103 | PRKACG | 0.35668882 |
| 104 | PAK2 | 0.35043190 |
| 105 | EIF2AK2 | 0.34102602 |
| 106 | MINK1 | 0.34019970 |
| 107 | TAOK2 | 0.33851444 |
| 108 | CSNK1E | 0.33625147 |
| 109 | DYRK1A | 0.33084259 |
| 110 | PRKD3 | 0.33048392 |
| 111 | ALK | 0.32573608 |
| 112 | PRKCA | 0.32429693 |
| 113 | PAK1 | 0.31337802 |
| 114 | EIF2AK3 | 0.30257889 |
| 115 | NEK6 | 0.29853507 |
| 116 | BMX | 0.28710261 |
| 117 | STK38 | 0.27919902 |
| 118 | CHEK1 | 0.27879835 |
| 119 | TYK2 | 0.27745365 |
| 120 | PDK3 | 0.27395871 |
| 121 | PDK4 | 0.27395871 |
| 122 | PRKAA1 | 0.27291453 |
| 123 | PAK3 | 0.26486568 |
| 124 | FLT3 | 0.26274834 |
| 125 | PRKACA | 0.26139015 |
| 126 | ERBB4 | 0.26088185 |
| 127 | EPHA4 | 0.25787708 |
| 128 | BUB1 | 0.25346933 |
| 129 | SRC | 0.24919627 |
| 130 | DYRK1B | 0.24813023 |
| 131 | CDK15 | 0.24408865 |
| 132 | PTK6 | 0.24272829 |
| 133 | CSNK1A1L | 0.23478568 |
| 134 | CSNK2A1 | 0.23452814 |
| 135 | KSR2 | 0.23369570 |
| 136 | CDK18 | 0.22823723 |
| 137 | CDK11A | 0.21930261 |
| 138 | GSK3A | 0.21853820 |
| 139 | WNK4 | 0.21787819 |
| 140 | MTOR | 0.21683128 |
| 141 | MAP2K2 | 0.21572263 |
| 142 | UHMK1 | 0.21345512 |
| 143 | SRPK1 | 0.21341261 |
| 144 | TAOK1 | 0.20363462 |
| 145 | LMTK2 | 0.19791049 |
| 146 | CDK19 | 0.19254241 |
| 147 | PRKACB | 0.18522725 |
| 148 | TESK2 | 0.18411883 |
| 149 | MAPKAPK3 | 0.17332223 |
| 150 | PDK2 | 0.17288265 |
| 151 | CDK2 | 0.16728236 |
| 152 | PRKD2 | 0.16641900 |
| 153 | CDK14 | 0.16256154 |
| 154 | ABL2 | 0.15841726 |
| 155 | CASK | 0.13684270 |
| 156 | DAPK2 | 0.13448640 |
| 157 | INSR | 0.12150731 |
| 158 | NTRK2 | 0.11047456 |
| 159 | DYRK3 | 0.11031445 |
| 160 | STK38L | 0.10721384 |
| 161 | RPS6KB2 | 0.10008834 |
| 162 | EPHB2 | 0.09849827 |
| 163 | MAPK10 | 0.09142586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.27820344 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.59416086 |
| 3 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.22803521 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.19318989 |
| 5 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.68219552 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60337444 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.43519144 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43445419 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 2.39985976 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.20950195 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20078661 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.14534966 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.99627128 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 1.96074869 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.90329329 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.85767983 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85350759 |
| 18 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.77942238 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.74208672 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64769237 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.63194594 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.59323471 |
| 23 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57052413 |
| 24 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54831424 |
| 25 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53148543 |
| 26 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53017012 |
| 27 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.51501470 |
| 28 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.48096974 |
| 29 | Peroxisome_Homo sapiens_hsa04146 | 1.47622339 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.45358398 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.45198433 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.40896752 |
| 33 | Bile secretion_Homo sapiens_hsa04976 | 1.35450604 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.35274075 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34312611 |
| 36 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.33408410 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.30306703 |
| 38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29970215 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28817798 |
| 40 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.27497039 |
| 41 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.26625423 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.25891354 |
| 43 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25309045 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.24812063 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24006206 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19380512 |
| 47 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.17595034 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15933728 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15711260 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.10131126 |
| 51 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.06962881 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06729316 |
| 53 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06622311 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02419055 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99128137 |
| 56 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.98846945 |
| 57 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.98246962 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.96465973 |
| 59 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95716225 |
| 60 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.94407128 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86754729 |
| 62 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83832228 |
| 63 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82531153 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.81938749 |
| 65 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.80331123 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.76481723 |
| 67 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74114015 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73913179 |
| 69 | Ribosome_Homo sapiens_hsa03010 | 0.70722715 |
| 70 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67714462 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67626687 |
| 72 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.64342250 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.62560157 |
| 74 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.60442427 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.58742680 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.58722391 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58626889 |
| 78 | DNA replication_Homo sapiens_hsa03030 | 0.58252882 |
| 79 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.52615595 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.52231474 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.50725917 |
| 82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49934114 |
| 83 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49916687 |
| 84 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.49077252 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.48271206 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.48131552 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44680494 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42163261 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.37498316 |
| 90 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.35869559 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.33897732 |
| 92 | Huntingtons disease_Homo sapiens_hsa05016 | 0.33523863 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.33409613 |
| 94 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32762632 |
| 95 | Base excision repair_Homo sapiens_hsa03410 | 0.30853299 |
| 96 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29713613 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27812848 |
| 98 | Mismatch repair_Homo sapiens_hsa03430 | 0.27750136 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.24725016 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.24597023 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24457144 |
| 102 | Mineral absorption_Homo sapiens_hsa04978 | 0.24205145 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.23793270 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.23660746 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.23647388 |
| 106 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.22757561 |
| 107 | Lysine degradation_Homo sapiens_hsa00310 | 0.21095379 |
| 108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.20550226 |
| 109 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.19986670 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19395532 |
| 111 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19117658 |
| 112 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.14456091 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.14236916 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14032534 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.13961421 |
| 116 | Protein export_Homo sapiens_hsa03060 | 0.13293984 |
| 117 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.12381931 |
| 118 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.11856832 |
| 119 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.10965002 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.08561753 |
| 121 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.08306490 |
| 122 | Purine metabolism_Homo sapiens_hsa00230 | 0.07547474 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.04521400 |
| 124 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.04328261 |

